MedTrace Logo

Procedure for Duodenum to Ileal Diversion to Treat Type 2 Diabetes

NCT03130244 · Status: ACTIVE_NOT_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 15

Last updated 2026-04-03

No results posted yet for this study

Summary

Study will monitor changes in HbA1c for subjects in Intervention arm vs control arm.

Conditions

Interventions

DEVICE

Magnet Anastomosis System

The MAS will be placed using an endoscope in the duodenum and and laparoscopically into ileum. A compression anastomosis will be created in each of the patients and the diversion of enteral flow from the duodenum to ileum treats Type 2 diabetes.

DRUG

Best Medical Management

The best medical management for the patients in this arm will be decided by the endocrinologist based on protocol parameters.

Sponsors & Collaborators

  • GI Windows, Inc.

    lead INDUSTRY

Principal Investigators

  • Rudolf H Buxhoeveden · Bariatric Surgeon at Hospital Aleman

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-09-23
Primary Completion
2026-01-15
Completion
2026-04-30

Countries

  • Argentina

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03130244 on ClinicalTrials.gov